CICigna Group

NYSE cigna.com


$ 333.55 $ -3.73 (-1.11 %)    

Thursday, 01-Aug-2024 11:51:11 EDT
QQQ $ 463.68 $ -10.20 (-2.15 %)
DIA $ 402.88 $ -7.16 (-1.75 %)
SPY $ 544.94 $ -7.63 (-1.38 %)
TLT $ 95.38 $ 0.32 (0.34 %)
GLD $ 226.15 $ -0.68 (-0.3 %)
$ 348.67
$ 337.28
$ 295.00 x 104
$ 387.00 x 155
$ 326.09 - $ 337.28
$ 251.86 - $ 364.21
1,466,143
na
97.47B
$ 0.89
$ 26.29
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-07-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-data-stock-performances-suggest-republican-win-in-november

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. Th...

 apple-amazon-microsoft-meta-lead-the-charge-as-investors-bank-on-tech-cheer-for-rallys-reacceleration-week-ahead-in-earnings

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say followin...

 bofa-downgrades-elevance-health-on-medicaid-pressure-and-lowered-peer-valuations

Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid me...

 healthcare-investors-bet-on-easier-medicare-rules-under-potential-trump-administration

Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks ...

 is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

 cantor-fitzgerald-reiterates-overweight-on-cigna-group-maintains-400-price-target

Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.

 ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

 cignas-specialty-pharmacy-leadership-expected-to-drive-long-term-eps-growth-analyst-says

Piper Sandler has initiated coverage on Cigna, highlighting its strong position in the specialty pharmacy market and robust gro...

 piper-sandler-initiates-coverage-on-cigna-group-with-overweight-rating-announces-price-target-of-400

Piper Sandler analyst Jessica Tassan initiates coverage on Cigna Group (NYSE:CI) with a Overweight rating and announces Pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION